Charlotte Gran
0000-0002-6069-6615
9 papers found
Refreshing results…
Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14)
Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma
Outcome of COVID‐19 in multiple myeloma patients in relation to treatment
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real‐life outcomes of daratumumab treatment
Treosulfan conditioning for allogeneic transplantation in multiple myeloma – improved overall survival in first line haematopoietic stem cell transplantation – a large retrospective study by the Chronic Malignancies Working Party of the EBMT
Translocation (11;14) in newly diagnosed multiple myeloma, time to reclassify this standard risk chromosomal aberration?
Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
Case Report: Treatment of light-chain amyloidosis with daratumumab monotherapy in two patients
Missing publications? Search for publications with a matching author name.